Table 2.
Major features of five meta-analyses
|
Ref.
|
Year
|
Total No. of study
|
Eradication group
|
Control group
|
OR/RR
|
95%Cl
|
||||
|
Total No.
|
Total events
|
Incidence rate
|
Total No.
|
Total events
|
Incidence rate
|
|||||
| Sugimoto et al[118] | 2020 | 4RCTs | 2731 | 73 | 2.7% | 2733 | 49 | 1.80% | 0.67 | 0.47–0.96 |
| Sugano et al[119] | 2019 | 32 | 16301 | 316 | 1.90% | 14805 | 535 | 3.60% | 0.46 | 0.39-0.55 |
| Doorakkers et al[120] | 2016 | 8 Cohort | 12899 | 119 | 0.90% | 18654 | 208 | 1.10% | 0.46 | 0.32-0.66 |
| Chen et al[121] | 2016 | 8RCTs | 3992 | 74 | 1.90% | 3962 | 116 | 2.90% | 0.64 | 0.48-0.85 |
| Ford et al[104] | 2014 | 6RCTs | 3294 | 51 | 1.60% | 3203 | 76 | 2.40% | 0.66 | 0.46-0.95 |
RR: Risk ratio; OR: Odds ratio; 95% C: 95% confidence interval.